AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vilciya M 1000mg/50mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Zuciya Lifesciences

Salt Composition

Metformin (1000mg) + Vildagliptin (50mg)

Overview Vilciya M 1000mg/50mg Tablet SR

Metformin/Vildagliptin 1000mg/50mg Extended-Release Tablets manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication mitigates the risk of severe diabetic complications like nephropathy and vision impairment, potentially lessening the likelihood of cardiovascular events. Prescribed independently or adjunctively with other antidiabetic therapies, its efficacy is maximized with a balanced diet and consistent physical activity. Dosage is personalized based on your health status, glucose readings, and concurrent medications. Ingesting it with food minimizes gastrointestinal discomfort. Consistent daily intake at the same time optimizes therapeutic benefits; discontinuation should only occur under physician guidance. Effective blood sugar regulation prevents long-term complications. Adherence to the recommended diet and exercise plan is crucial. Lifestyle significantly impacts diabetes management. Common adverse reactions may encompass diarrhea, nausea, emesis, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential consequence when used concurrently with insulin or sulfonylureas; proper identification and management of this side effect are essential. This medication isn't universally appropriate. Prior to initiating treatment, inform your physician of any pre-existing renal, hepatic, or cardiac conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation. Potential drug interactions necessitate disclosure of all medications to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout your treatment.

Primary Ingredients of Vilciya M 1000mg/50mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Vilciya M 1000mg/50mg Tablet SR

Managing type 2 diabetes

Major Benefits of Vilciya M 1000mg/50mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vilciya M 1000mg/50mg Tablet SR whole; do not crush, chew, or divide it. Administer this extended-release tablet with a meal.

Common Side effects of Vilciya M 1000mg/50mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vilciya M 1000mg/50mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Vilciya M 1000mg/50mg Tablet SR should be swallowed whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this medication with food.

How Vilciya M 1000mg/50mg Tablet SR works:

Each Vilciya M extended-release tablet (1000mg/50mg) contains a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vilciya M 1000mg/50mg SR tablets with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Vilciya M 1000mg/50mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Vilciya M 1000mg/50mg tablets are likely unsuitable for breastfeeding mothers. Preliminary human evidence indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Vilciya M 1000mg/50mg Tablet SR. Dosage modification of Vilciya M 1000mg/50mg Tablet SR might be necessary. A physician's consultation is advised.

LiverLiverUNSAFE

Use of Vilciya M 1000mg/50mg SR tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Vilciya M 1000mg/50mg Tablet SR :

Should you forget to take a Vilciya M 1000mg/50mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vilciya M 1000mg/50mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vilciya M 1000mg/50mg Tablet SR

Vilciya M 1000mg/50mg SR tablets rarely cause hypoglycemia (low blood sugar) by themselves. However, hypoglycemia can develop if insufficient calories are consumed while taking this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may indicate low blood sugar. These symptoms are more likely if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source like glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vilciya M 1000mg/50mg Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Consult your doctor before taking any other medication.
Patients with known allergies to Vilciya M 1000mg/50mg Tablet SR components or excipients should not use this medication. Its use is contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vilciya M 1000mg/50mg SR tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vilciya M 1000mg/50mg Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the drug in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Vilciya M and seek immediate medical attention.
Prolonged use of Vilciya M 1000mg/50mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Using Vilciya M 1000mg/50mg SR tablets as directed by your doctor is safe. However, even with correct usage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent issues to your doctor.
Vilciya M 1000mg/50mg Tab...
160
MRP 185
13% off